Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2020 07:00 ET | Source: BeiGene, LTD.

EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® and QARZIBA®▼ in Greater China

- SYLVANT® and QARZIBA®▼ recently listed for fast-track approval in China – - Expands EUSA’s global product offering; broadens BeiGene’s portfolio – HEMEL HEMPSTEAD, England and CAMBRIDGE, Mass. and...